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The study was designed to explore the biochemical inﬂuence of non bonding nitrogen interactions
(N  Se/S) on organochalcogens potency. Approximately ﬁve and six times higher thiol peroxidase
(TPx) like activity was observed for compound (C)-2 than C-1 and C-3, respectively. C-2 also displayed
signiﬁcantly (p < 0.05) higher activity in 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical scavenging and
deoxyribose degradation assays. All compounds, except C-4 and C-6 signiﬁcantly inhibited Fe (II) and
sodium nitroprusside (SNP) induced thiobarbituric acid reactive species (TBARS) production in rat’s brain,
liver and kidney preparations with highest activity observed for C-2. The highest C-2 activity was attrib-
uted to the presence of non-bonded nitrogen interactions which were absent in C-1 and blocked with
butoxycarbonyl (BOC group) in C-3. The same structural activity analogy was extended to organosulfur
compounds and it was observed that compound with non-bonding nitrogen interactions, i.e. C-5 has sig-
niﬁcantly (p < 0.05) higher TPx like activity than C-6 and C-4. C-5 at the highest tested concentration sig-
niﬁcantly (p < 0.05) protected against Fe (II) and SNP induced TBARS formation in rat’s brain, kidney and
liver preparations but did not display activity in DPPH and deoxyribose degradation assays. This study
conﬁrms the inﬂuence of not only N  Se interaction but also for the ﬁrst time the effect of non bonded
N  S interactions on organochalcogens potency. C-2 (with the highest activity) was also tested in vivo
and was administered at three different doses, i.e. 15, 30 and 50 mg/kg to get an exact idea about its
interaction with thiol containing molecules (NPSH) and enzyme a-ALA-D (sulfhydryl containing
enzyme). Oxidative stress parameters, i.e. free radical concentration by dichloroﬂuoreseein (DCF) assay,
TBARS, ascorbic acid level, hepatic (ALT and AST) and renal (urea and creatinine) toxicity markers were
also estimated to get an insight about its possible toxicological proﬁle. Our data indicates that C-2 has
higher TPx and Antioxidant activity and importantly, C2 did not induce toxicity even when tested at rel-
atively high doses, indicating that its pharmacological properties should be further explored in models of
diseases associated with oxidative stress.
 2012 Elsevier Ireland Ltd.Open access under the Elsevier OA license.1. Introduction
Since the ﬁrst report on the synthesis of ebselen in 1924 by Les-
ser et al. [1] several further methods have been reported to explain
the biochemical efﬁcacy of organochalcogens which carries a direct
Se–N bond. In this regard Jacquemin et al. [2] reported the ebselen
homologue in which a supplementary tetrahedral carbon (–CH2–
group) is incorporated into the heterocycle. The resulting com-
pound showed low toxicity and higher GPx activity. Reich et al.
[3] reported the synthesis and redox chemistry of selenenamide.
Furthermore substituents effect on these molecules were studiedax: +55 55 3220 8978.
. Hassan), jbtrocha@yahoo.
er the Elsevier OA license.in detail, where by introducing a –CH2– group into the heterocycle
increased the observed glutathione peroxidase (GPx) activity [4].
The importance of the Se–N linkage for GPx activity was reported
by Galet et al. [5]. He proved that compounds that do not have
any direct Se–N bond were devoid of GPx activity. The work by
Wilson et al. [6] to design GPx mimics without direct Se–N bond
also met with only limited success.
Further developments in the area have started in accordance
with the ﬁnding that the active selenocysteinyl residue at the cat-
alytic site of GPx may be involved in some interactions with other
amino acid residues that would alter the enzyme’s activity. In this
regard, Flohé et al. [7] studied the simulation of the catalytic cycle
of GPx by computer assisted molecular modeling. According to this
model, the selenium in the active site interacts weakly with the
imino group of Trp 165 and the amido group of Gln 87 (SeN
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tions various organoselenium compounds containing heteroatoms
in close proximity to the selenium have been synthesized in order
to study their GPx activity. Wilson et al. reported that diselenides
which possesses basic amino nitrogen near the selenium, exhibit
strong GPx antioxidant activity. While Tomoda et al. [8] studied
the effect of an amino group on the antioxidant activity of GPx
by using various model compounds. The results of these studies
were in agreement with the report of Wilson et al. [6]. However,
there is still scarcity of data in the literature about the exact mech-
anism of action and efﬁcacies of these compounds apart from their
observed GPx like activity.
The ﬁeld of amino acids has gained enormous popularity, par-
ticularly with the emergence of unnatural analogs as components
of molecules with therapeutic potential [9]. In particular the syn-
thesis of peptides containing selenium or sulfur atom is rapidly
gaining interest with the discovery of an increasing number of bio-
molecules containing these compounds [10,11]. Although the
importance of amino acid residues incorporated in organochalco-
gens have been proven and reported in some reports [12,13] but
the entire activity spectrum of these interesting biomolecules still
lacks in literature. The objective of the work is to study small a,b-
amino acids derived organochalcogens for their anti-oxidant activ-
ity and how does the presence of non-bonding nitrogen interaction
effect their entire anti-oxidant potential and general toxic behav-
ior. In this regard we are reporting a structure–activity based study
which will help us to explore the effects of non-bonding nitrogen
interactions in pure chemical model systems, i.e. thiol peroxidase
(TPx) Assays, DPPH radical scavenging assays and deoxyribose deg-
radation assay. We will also explore if these possible non-bonding
interactions really play an important role in inhibiting Fe (II) and
Sodium Nitroprusside (SNP) induced lipid peroxidation processes
in brain, liver and kidney homogenates, i.e. biological samples.
Organoselenium compounds can interact directly with low
molecular thiols, oxidizing them to disulﬁdes as well [14]. Simi-
larly, reduced cysteinyl residues from proteins can also react with
these compounds, which may cause, in the case of the enzymes,
the loss of their catalytic activity [15,16]. The mechanism(s) under-
lying either the toxic or protective effect of organochalcogens are
not completely understood but certainly involves the reaction of
chalcogenides with endogenous thiols [17,18]. In this regard an
in vivo study is designed to study the interaction proﬁle of the
most active compound (selected from in vitro work) with a-ALA-
D (sulfhydryl containing enzyme) and non protein thiol content
(NPSH) in brain, liver and kidney preparations. Possible oxidative
damage to the rats will be estimated by measuring thiobarbituric
acid reactive species (TBARS) production, free radical concentra-
tion measurements by DCFH oxidation assay, and ascorbic acid lev-
els in all three tissue homogenates. Several other tests will be
performed to get a detail idea about its in vivo behavior which
could be of particular interest in view of its pharmacological and
toxicological potential of organochalcogens.2. Material and methods
2.1. Synthesis of organoselenieds and sulﬁdes
The diorganyl selenides and sulphides and DPDS (Table 1) were
synthesized using the literature procedure [19,20]. Analysis of the
1H NMR and 13C NMR spectra showed that the compound obtained
presented analytical and spectroscopic data in full agreement with
their assigned structure. The chemical purity of the compound
(99.9%) was determined by GC/HPLC. Diphenyl disulphide (CAS
No: 882–33-7) was purchased and used for the experiments.2.2. In-Vitro analysis
2.2.1. Thiol peroxidase activity
The catalytic activity of all compounds (Table 1) as a GPx model
enzyme was evaluated according to Tomoda and Iwaoka method
[8] using benzenethiol as a glutathione alternative. The reduction
of H2O2 was monitored through the UV absorption increase at
305 nm, due to diphenyl disulﬁde formation.
2.2.2. Animals
Adult male wistar rats from our own breeding colony (250–
350 g) were maintained in an air-conditioned room (22–25 C) un-
der natural lighting conditions, with water and food (Guabi, RS,
Brazil) ad libitum. Animals were used according to the guidelines
of the Committee on Care and Use of Experimental Animal Re-
sources, School of Veterinary Medicine and Animal Science of the
University of São Paulo, Brazil.
2.2.3. Tissue preparation
Animals were anesthetized with ether and killed by decapita-
tion. Brain was quickly removed, placed on ice, and homogenized
within 10 min, in 10 mmol/l Tris/HCl buffer, pH 7.4 (in 10 volume).
The homogenate was centrifuged at 4000g at 4 C for 10 min to
yield a low speed supernatant fraction (S1) that was used immedi-
ately for TBARS assay [21].
2.2.4. Lipid peroxidation assay
Lipid peroxidation was determined by measuring TBARS as de-
scribed by Ohkawa et al. [22] with little modiﬁcations [21] in S1 of
brain. Aliquots of S1 (200 lL) were mixed to incubating medium
containing Tris–HCl (0.01 mM) pH 7.4, the compounds at different
concentrations. Iron (II) and sodium Nitroprusside (SNP) pro-oxi-
dants were added as positive control for lipid peroxidation. Next,
the mixture was incubated at 37 C for 60 min. The basal or pro-
oxidant-induced TBARS production was stopped by adding
0.5 mL of acetic acid buffer (pH 3.5), and lipid peroxidation prod-
ucts were measured by the addition of 0.5 mL of TBA 0.6%. Tubes
were then incubated in boiling water for 60 min and their contents
were subjected to spectrophotometric analysis. The amount of
TBARS produced was measured at 532 nm, using MDA as an exter-
nal standard. TBARS levels were expressed as nmol MDA (malondi-
aldehyde)/g of tissue.
2.2.5. DPPH radical scavenging assay
The measurement of radical scavenging activity of all com-
pounds against the radical DPPH (1,1-diphenyl-2-picrylhydrazyl)
was performed in accordance with Choi et al. [23]. Brieﬂy, 85 lM
DPPH was added to a medium containing different compounds
concentrations. The medium was incubated for 30 min at room
temperature. The decrease in absorbance measured at 518 nm de-
picted the scavenging activity of the tested compounds against
DPPH. Ascorbic acid was used as positive control to determine
the maximal decrease in DPPH absorbance. The values are ex-
pressed in percentage of inhibition of DPPH absorbance (% inhibi-
tion) in relation to the control values without the tested
compounds (ascorbic acid maximal inhibition was considered
100% of inhibition).
2.2.6. Deoxyribose degradation assay
The deoxyribose degradation assay was performed according to
Puntel et al. [21]. Reaction mixtures were incubated at 37 C for
30 min and stopped by the addition of 0.8 mL of trichloroacetic
acid (TCA) 2.8% followed by the addition of 0.4 mL of thiobarbituric
acid (TBA) 0.6%. Next, the medium was incubated at 100 C for
20 min and the absorbance was recorded at 532 nm. Standard
curves of malondialdehyde (MDA) were made in each experiment
Table 1
Structure of b-amino diselenides and sulﬁdes.
Organoselenium (Se) compounds
Compound number Name Structure Characteristic
C-1 Diphenyl diselenide
Se
Se
2 2
Parent compound, i.e. absence of adjacent nitrogen
C-2 b-Amino diselenide (a) Presence of nitrogen (unprotected)
C-3 b-Amino diselenide (b) Nitrogen protected with BOC group
Organosulfur (S) compounds
C-4 Diphenyl disulﬁde
S S
2 2
Parent compound, i.e. absence of adjacent nitrogen
C-5 b-Amino disulﬁde (a) Presence of nitrogen (unprotected)
C-6 b-Amino disulﬁde (b) Nitrogen protected with BOC group
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degradation.
2.3. In-vivo analysis
In view of the in vitro antioxidant properties presented by C-2
and to gain better understanding of its pharmacological behavior
several toxicological parameters were assessed in vivo and ex vivo.
2.3.1. Animal’s treatment
Rats were divided into four groups each containing six [6] rats,
daily weighted and treated (orally) for 3 days (at the interval of
24 h) with C-2 at 0 (Canola oil) 10, 25 and 50 mg/kg. 24 h after
the last injection animals were anesthetized to the collection of
blood via heart puncture in tubes containing heparin, and then
killed by decapitation. Plasma was obtained by centrifugation at
2000g for 10 min (hemolyzed plasma was discarded). All groups
were killed by decapitation and the brain, liver and kidney were
quickly removed and homogenized in 10 vol. of 50 mM Tris–HCl,
pH 7.4. The homogenate was centrifuged at 4000g at 4 C for
10 min and a low supernatant fraction (S1) was used for ex vivo
assays.
2.3.2. Lipid peroxidation
The low supernatant fraction (S1) brain, liver and kidney were
used for thiobarbituric acid-reactive species (TBARS) assay accord-
ing to Ohkawa et al. [22] and Puntel et al. [21]. Samples were incu-
bated at 95 C for 120 min. The amount of TBARS produced was
measured at 532 nm, using MDA as an external standard. TBARS
levels were expressed as nmol MDA (malondialdehyde)/g of tissue.
2.3.3. Oxidation of DFCH
To estimate the level of total ROS production, samples (50 ll)
were diluted (1:10) in Tris-Buffer (pH 7.4). The oxidation of 20,70-
dichloroﬂuorescein diacetate (DCHF-DA) to ﬂuorescent DCF was
measured for the detection of DFC reactive species (DCF-RS) using
the method described in Colpo et al. [24]. The DCF ﬂuorescenceintensity emission was recorded at 520 nm (with 480 nm excita-
tion) 60 min after the addition of DCHF-DA (12 ll) to the medium
using a ﬂuorescence spectrophotometer (Hitachi F-2000; Hitachi,
Tokyo, Japan).
2.3.4. d-ALA-D activity
d-ALA-D activity from brain, liver and kidney were assayed by
the method of Sassa [25] by measuring the rate of product porpho-
bilinogen (PBG) formation (expressed as nmol PBG/mgptn/h). The
reaction product was determined using modiﬁed Erlich’s reagent
at 555 nm.
2.3.5. Nonprotein thiols (NPSH) content
Cerebral, hepatic and renal NPSH levels were determined by the
method of Ellman [26]. A sample of supernatant (500 lL) was
mixed (1:1) with 10% trichloroacetic acid (500 lL). After centrifu-
gation, the protein pellet was discarded and free –SH groups were
determined as nmol/g tissue in a clear supernatant. An aliquot
(100 lL) of supernatant was added in a 1 M potassium phosphate
buffer (850 lL), pH 7.4, and 10 mM 5,50-dithio-bis(2-nitrobenzoic
acid) (DTNB) (50 lL). The color reaction was measured at 412 nm.
2.3.6. Ascorbic acid level
Brain, liver and kidney’s ascorbic acid level at the highest tested
dose was estimated by the method of Jacques-Silva et al. [27] The
reaction product was determined as lg AA/g tissue using color re-
agent containing 4.5 mg/mL dinitrophenyl hydrazine and CuSO4
(0.075 mg/mL).
2.3.7. Hepatic and renal markers of damage
Plasma enzymes AST (aspartate aminotransferase) and ALT (ala-
nine amino transferase) expressed as U/dlwere used as the bio-
chemical markers for the early acute hepatic damage and
determined by the colorimetric method of Reitman and Frankel
(1957) [28]. Renal function was analyzed by determining plasma
urea (Mackay and Mackay, 1927) [29] and creatinine levels which
are expressed as mg/dl (Jaffe, 1986) [30].
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The results are expressed as the mean ± standard error (SEM).
Data were analyzed statistically by analysis of variance (Two-
way ANOVA), followed by univariate analysis and Duncan’s multi-
ple range test when appropriate.Fig. 2. Thiol Peroxidase like activity of organosulfur compounds.3. Results
3.1. In-vitro tests
Fig. 1 demonstrates the TPx data of organoselenium com-
pounds. It is apparent from the ﬁgure that C-2 showed ﬁve and
six times higher thiol peroxidase activity than DPDS (C-1) and
(C-3). Organosulfur compounds exhibited (Fig. 2) signiﬁcantly
low TPx potential than their selenium homologues but it is impor-
tant to note that C-5 characterized by the presence of adjacent
nitrogen close to sulfur has higher TPx activity than C-6. C-4
(DPD-sulﬁde did not show any TPx activity, data now shown). In
line with TPx activity C-2 signiﬁcantly reduced both Fe (II) induced
(Fig. 3) and SNP induced TBARS (Fig. 4) formation in rat’s tissue
homogenate than C-1 and C-3. However, the sulfur analogs were
less potent apart from C-5 which signiﬁcantly protected both Fe
(II) induced (Fig. 5) and SNP induced TBARS formation (Fig. 6) at
the highest tested concentration in rat’s tissue homogenate. C-2
prevented deoxyribose degradation induced by Fe (II), H2O2 or Fe
(II) + H2O2 (Table.2) (p < 0.05). In addition C-2 (organoselenium)
and C-5 (organosulfur) which was characterized by the presence
of non-bonding nitrogen interaction strongly exhibited DPPH rad-
ical scavenging assay as shown in Table 3.3.2. In-vivo results
C-2 was selected from in vitro work for its higher anti-oxidant
potential and was administered at three doses to get an insight
about its toxic proﬁle. It is apparent from (Fig. 7) that the com-
pound C-2 did not cause any oxidative damage as measured by
TBARS formation in all tissue homogenates as compared with con-
trol. Similarly treatment with this compound did change DFC-RS
production as shown in (Fig. 8). ALA-D (from rats’ brain, liver and
kidney, Fig. 9) activity was not inhibited by the administration of
the tested compound. While, Two-way ANOVA revealed that C-2
signiﬁcantly increased NPSH concentration at the highest tested
concentration in all tested homogenates (Fig. 10). Ascorbic acid le-
vel remains un-changed after acute treatment with C-2 as shown
in (Fig. 11). AST and ALT plasmatic activities, Urea and Creatinine
levels were not increased after exposure to different doses of C-2
indicating that hepatic and renal damage was not detected
(Fig. 12).Fig. 1. Thiol Peroxidase like activity of organoselenium compounds.4. Discussion
Reich and Jasperse observed that under neutral conditions the
diselenides and selenosulﬁdes do not react with thiols, however,
upon the addition of a strong amino base both gave selenolate
and disulﬁdes [3]. These results motivated us for our synthetic part
and we managed to synthesize (according to literature methods)
phenyl alanine derived organoselenium and organosulfur analogs.
The idea was to have an adjacent hetero-atom, i.e. Nitrogen in close
proximity of the central atom (Se or S) which may possibly gener-
ate these small non-bonding interactions. The inclusion or the
introduction of this nitrogen proximal to active selenium or sulfur
is desirable as it would be expected to catalyze the reactions of thi-
ols with possible intermediate diselenides or disulﬁdes. Similarly
wendel and co-workers [31] proposed that the presence of amino
acid residues near the selenium atom might interact weakly with
selenium which could helps in stabilizing the active selenolate.
This is what we observed in our results, which showed that C-2
has signiﬁcantly higher thiol peroxidase (TPx) activity than C-1
and C-3.
We can theoretically explain the above results by assuming a
hypothetical cycle (as proposed by Iowka and Tomoda) for our
amino acid derived compounds (Scheme 1). The initial step is the
reaction of C-2 with PhSH to produce selenyl sulﬁde. Because of
the hypervalent Se–N interaction the selenyl sulﬁde is feasibly con-
verted into selenolate ion. Selenolate is further oxidized by H2O2 to
produce selenenic acid which upon reaction with PhSH regenerate
initial C-2 molecule. The ease of formation and stability of the sel-
enolate ion or selenol (zwitterionic ion) is the key step which is to-
tally different than the normal proposed cycle of C-1, i.e. DPDS
where the compound does not contain any of these non bonding
or hypervalent interactions and are blocked with bulky BOC group
in C-3.
The presence of amine group (Nitrogen) may serve the deproto-
nation of thiol sulfyhydryl group and thus provide a high local con-
centration of thiolate anion. Similarly it is also possible that the
conjugate base of amine (ammonium ion) obtained upon abstrac-
tion of hydrogen from –SH group serves as proton source which
further facilitates the reduction of hydrogen peroxide to water.
[6]. This comprehensively conﬁrms the assumptions that the C-2
with proximal nitrogen which is responsible for small non-bonding
interaction contribute profoundly towards the thiol peroxidase
activity (Fig. 1). It is interesting to note that organosulfur com-
pound usually have smaller TPx activity than selenium analogs
as the parent compound Diphenyl disulﬁde (C-4) did not display
any TPx acitivity (data not shown). But the compound C-5 which
could exhibit with these small non-bonding nitrogen interaction
showed higher TPx activity than its homologue C-6 where the
interactions were blocked with bulky BOC group (Fig. 2). To the
Fig. 3. Effect of organoselenium compounds on Fe (II) Induced TBARS formation.
Fig. 4. Effect of organoselenium compounds on SNP Induced TBARS formation.
Fig. 5. Effect of organosulfur compounds on Fe (II) Induced TBARS formation.
Fig. 6. Effect of organosulfur compounds on SNP Induced TBARS formation.
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niﬁcant effect of non-bonding nitrogen interaction on TPx activity
of diorganoyl disulﬁde compounds.Under normal experimental conditions TPx gives us background
information about the possible reducing behavior (Antioxidant
character) of organochalcogens. But it is critical to note that higher
Table 2
Effect of organoselenium and organosulfur compounds o Fe (II) induced deoxyribose
degradation assay. Asterisk (⁄) indicates signiﬁcant difference from control.
Compound number Absorbance at 532 nm corresponding to TBARS
formation
H2O2 Fe (II) Fe (II) + H2O2
Control 0.332 0.536 0.753
C-1 0.312 0.513 0.765
C-2 0.255⁄ 0.412⁄ 0.639⁄
C-3 0.324 0.543 0.762
C-4 0.331 0.511 0.767
C-5 0.345 0.523 0.734
C-6 0.312 0.554 0.743
Fig. 7. Effect of in vivo treatment of
Fig. 8. Effect of in vivo treatment of C-2
Fig. 9. Effect of in vivo treatm
W. Hassan et al. / Chemico-Biological Interactions 199 (2012) 96–105 101TPx activity may not reﬂect improved or signiﬁcantly better anti-
oxidant potential (Unpublished data). The plausible explanation
for this possible contrasting behavior between thiol peroxidase like
activity and TBARS inhibitory activities could be that although TPx
measurements are typically used to determine antioxidant activity
of organochalcogens, these measurements may not accurately re-
ﬂect cellular conditions. TPx activity measurements are often
determined under conditions that are not physiologically relevant,
such as using non-aqueous solutions or non-biological thiols. For
example, a common method for TPx activity determination in-
volves oxidation of benzenethiol (PhSH) to the disulﬁde (PhSSPh)
in methanol. Similarly, small changes in experimental technique
can greatly affect TPx measurements. Lastly, H2O2 is a relativelyC-2 on in vivo TBARS formation.
on in vivo free radical production.
ent of C-2 ALA-d activity.
Fig. 10. Effect of in vivo treatment of C-2 on NPSH level.
Fig. 11. Effect of in vivo treatment of C-2 on ascorbic acid level.
Fig. 12. Effect of in vivo treatment of C-2 on hepatic and renal toxicity markers.
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Scheme 1. Proposed mechanistic cycle of DPDS and C-2.
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pared to the hydroxyl radical, one of the most highly reactive and
deleterious radical species. Based on above stated measures and on
our own results (unpublished data) we can conclude that anti-oxi-
dant potential evaluated by thiol peroxidase system could not nec-
essary be extrapolated to biological samples. Therefore we shifted
to more classical protocols like TBARS, DCFH-Assay and DPPH scav-
enging assay to get an idea about the potential anti-oxidant activ-
ity and to decode whether small hypervalent interaction alters
these activities.
It is worthy to note that TBARS method is not an accurate assay
and may have some limitations such as the detection of products
that are not derived from lipid peroxidation as well as the potential
interference of factors such as high temperature that may cause
artefactual formation of lipid peroxidation products during color
development, this method has been extensively used as a marker
of LPO in biological materials. In this regard we have recently
[32] compared the Ohkawa’s colorimetric method with a high per-
formance liquid chromatographic (HPLC) analysis. Results were
similar for the two methods and the artefactual increase in TBARS
production during color development did not occur due to the
presence of SDS in medium. Since in the HPLC method, the adduct
formed corresponded to the reaction of TBA with MDA (which is
derived from unsaturated fatty acid decomposition after oxidative
stress insult it is possible to assert that TBARS can be considered a
good and reliable method to determine the oxidative stress in bio-
logical samples.
We have also demonstrated that Fe (II) and SNP can induce oxi-
dative stress as evident by increased TBARS formation in rat’s
brain, liver and kidney homogenate. All organoselenium com-
pounds signiﬁcantly protected both Fe (II) and SNP TBARS forma-
tion with the highest activity observed for C-2 (Figs. 3 and 4).
The differences observed in the C-2 activity depending of the
pro-oxidant used might be related to the different mechanism by
which they exert their oxidative damage. Photo degradation of
SNP produces NO, and various other oxidizing species [33,34].
The NO is a free radical with a short half-life (30 s) and it may cause
neuronal damage in cooperation with other ROS [35,36]. The iron
moiety of SNP may have a free iron coordination site for H2O2,
which could trigger the generation of highly reactive oxygen spe-
cies, such as OH via the Fenton reaction [37]. In this study, we
demonstrate that SNP, a NO donor, can induce lipid peroxidation
in vitro, in rat’s tissue homogenates (Figs. 4 and 6). The result pre-sented in (Figs. 4 and 6) indicated that both organoselenium and
organosulfur compounds exerted an antioxidant effect on in vitro
SNP induced lipid peroxidation in rat’s tissue homogenate with
highest activity observed for C-2. It should also be noted that
SNP molecules may help in some iron complexes formation, i.e.
pentacyanoferrate complex, which could lead to oxidative reac-
tions involved in RS generation. Data from the literature have
showed that Fe (II) may cause its oxidative damage not only by
producing O21, H2O2 and OH1, but also by some active form of
iron-oxygen complexes such as ferryl ion [38], perferryl ion [39]
and Fe2—O2—Fe3 complexes [40]. A plausible mechanism by
which C-2 is conferring protective action against Fe (II) and SNP in-
duced lipid peroxidation in these homogenates is that C-2 could
not only be working as a scavenger, as apparent from DPPH scav-
enging assay but may also be interacting directly with Fe (II) or
its oxidized forms. The higher C-2 Protection can also be attributed
to its higher TPx activity. In strong contrast to organoselenium
compounds the sulfur analogs did not display potent activity,
and only C-5 at the highest tested concentration protected against
Fe (II) and SNP induced TBARS formation.
The Fe (II) induced basal oxidation can be written in the form of
below reaction;
Fe2þ þ O2 ! Fe3þ þ O12
The superoxide produced in above reactions may react with
H2O2 or any lipid peroxide (LOOH) in a metal catalyzed (Haber–
Weiss reaction) to produce the extremely reactive hydroxyl radical,
which may then abstract hydrogen atoms from polyunsaturated
fatty acids.
Fe2þ þ O12 þ 2Hþ ! Fe3þ þH2O2;
While, Fenton Reaction can be summarized below.
Fe2þ þH2O2 ! Fe3þ þ OH1 þ OH
Ferrous ion (Fe (II)) is the form of iron that is capable of redox
cycling. Oxidation of Fe (II) to Fe (III) results in ROS formation.
The possibility of reduction of Fe (III) to Fe (II) by interaction with
O21 at the early phase of lipid peroxidation under acidic condi-
tions, perhaps via an intermediate, perferryl iron cannot be ex-
cluded. We can conclude from these above simple reactions that
an important mechanism to accelerate the intracellular compo-
nents dysfunction is caused by Fe (II) + H2O2 reaction that can lead
Table 3
Effect of organoselenium and sulfur compounds on DPPH radical scavenging assay.
Asterisk indicates signiﬁcant (p < 0.05) difference with respect to control.
Concentration (ll) Organoselenium
compounds
Organosulfur compounds
C-1 C-2 C-3 C-4 C-5 C-6
0 (Control) 100 100 100 100 100 100
10 97 ± 3 92 ± 3 99 ± 7 95 ± 4 94 ± 6 97 ± 3
50 97 ± 2 72 ± 4⁄ 94 ± 6 97 ± 6 90 ± 4 92 ± 7
100 95 ± 5 39 ± 6⁄ 92 ± 8 94 ± 3 82 ± 2⁄ 96 ± 4
200 95 ± 3 19 ± 4⁄ 102 ± 5 99 ± 7 61 ± 4⁄ 91 ± 7
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cellular components dysfunction is caused by Fe (II) + H2O2 reac-
tion that can lead to OH formation [41]. A classical model to
evaluate the interaction between different agents and in vitro
OH formed via Fe (II) + H2O2 reaction is the deoxyribose degrada-
tion assay [42,43]. Our results (Table 2) indicate that the C-2 effec-
tively decreased deoxyribose degradation induced by Fe (II) or Fe
(II) + H2O2 at the highest tested concentration suggesting an
important effect against Fe (II) and OH formed via Fe (II) + H2O2
reaction. It is possible to predict from these results that the C-2
might be interacting not only with the free radicals (by scavenging
them) but may also be interacting with Fe (II) or any of its oxidized
form which consequently reduce the extent of damage. In order to
elucidate the ability of these compounds towards different free
reactive species, we tested their radical scavenging activity. The re-
sults demonstrate that C-2 has the ability to neutralize the DPPH
radical as showed in (Table 3) which could be attributed to its thiol
peroxidase like activity. Organoselenium compounds (Table 3)
showed higher DPPH activity than their sulfur homologues as
shown in (Table 3).
We have proved from the above in vitro results that C-2 with
non bonding nitrogen interaction has signiﬁcantly higher anti-oxi-
dant potential and can be considered a potential compound for
in vivo work. Since there is no data in the literature about the acute
treatment of this compound and its possible toxicological proﬁle,
we designed a simple study where the compound was adminis-
tered at three doses, i.e. low, medium and high to get an exact idea
about its in vivo behavior. The in vivo concentration were derived
from our in vitro data (Figs. 1–6 and Tables 2 and 3) which shows
very signiﬁcant antioxidant potential at low concentration (5–
10 lM for Fe and SNP TBARS). It is very difﬁcult of get an exact idea
about the possible in vivo dose which would be sufﬁcient enough
to reduce the oxidative damage at a level which we obtained
in vitro. But based on our previous report where we proved that
DPDS at a concentration higher than 100 lM is associated at liver
damage, we decided to use an in vivo dose that was about 10–50
times lower than that used for DPDS.
Orgachalcogens can be cytotoxic via their ability to catalyze the
oxidation of thiols and to generate free radicals and subsequent li-
pid peroxidation [44,45]. However, treatment with C-2 did not
cause any oxidative stress as measured by TBARS formation
(Fig. 7). There is considerable amount of data which shows that
free radicals are involved in the biochemical mechanisms underly-
ing various neurodegenerative or a number of pathological disor-
ders in human and anti-oxidant therapy have profoundly
recuperated the oxidative damage [46]. The free radicals usually
affect biomolecules, such as proteins, lipids and DNA, and mito-
chondria [48]. However, treatment with C-6 was not associated
with any increase in free radical concentration as shown in
Fig. 8. Supporting the absence of ex vivo prooxidant activity of C-
2 are the results on d-ALA-D activity. d-Aminolevulinate dehydra-
tase (d-ALA-D) is a sulfhydryl containing enzyme that is inhibited
by a variety of sulfhydryl reagents [48,49]. This enzyme catalyzesthe condensation of two d-aminolevulinic acid (ALA) molecules
with the formation of porphobilinogen, which is a heme precursor
[50]. Consequently, d-ALA-D inhibition may impair heme biosyn-
thesis [51] and can result in the accumulation of ALA, which may
affect the aerobic metabolism and may have some prooxidant
activity [52]. Data from our laboratory have shown that d-ALA-D
activity is signiﬁcantly inhibited by diphenyl diselenide [53]. Our
results on d-ALA-D activity (Fig. 9) conﬁrms our supposition that
the stated enzyme is not a molecular target of C-2, infact treat-
ments with C-2 enhanced NPSH content (Fig. 10) which further
proves the safe side of the compound as far as its interaction with
thiol group is concerned.
Exposure to C-2 did not alter vitamin C levels in brain, liver and
kidney (Fig. 11) which conﬁrms a safe position for the possible
treatment of oxidative stress related disorder. Taken together,
these data suggest that acute exposure to C-2 did not induce oxida-
tive stress in rats. Plasmatic transaminase activities, i.e. AST and
ALT are located in different subcellular spaces in hepatocytes,
and they are typically released into the blood after exposure to
hepatotoxic chemical agents [54]. These are typical conventional
enzymatic activities used to get an idea about the hepatotoxic ef-
fects of a compound. Rats exposed to C-2 had markers of hepatic
and renal function within the normal range (Fig. 12). In the same
end, acute exposure to high doses of DPDS did not affect plasma
transaminase activities or levels of urea and creatinine in rodents
[45]. Furthermore, previous study has reported that rabbits chron-
ically exposed to DPDS supplemented diet have levels of markers
of hepatic and renal functions within the normal range [55].
The present study was designed carefully and by looking at the
structural characteristics of organoselenium compound (speciﬁ-
cally) we can see that C-1 does not contain any nitrogen interaction
(absence of nitrogen atom) which are present in C-2 and blocked
with bulky steric group (BOC) in C-3. Literature data about similar
compounds reveals that both theory (Molecular Orbital (MO) cal-
culations) and experiments (77Se NMR) suggest that the proximate
nitrogen base activates the selenol intermediate into correspond-
ing selenolate anion, which should play a key role in accelerating
the catalytic cycle. Literature has provided detail information
about the possible rate constants of similar compounds but did
not provide extensive insight to their possible in vitro or in vivo
behavior [56]. We have proved for the very 1st time from both
in vitro and in vivo data the very signiﬁcant antioxidant potential
and non toxic effect of C-2. To the best of our knowledge this is
the 1st comprehensive report which proves the effect of non bond-
ing nitrogen interaction not only on organoselenium compounds
but also towards organosulfur compounds.5. Conﬂict of interest statement
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